PEAR BIO
Pear Bio uses organ-on-a-chip and computer vision technology to recreate, visualize, and compute the human tumor microenvironment and its effects on cancer progression. The company was founded in 2017 and is headquartered in London.
PEAR BIO
Industry:
Biotechnology Health Care Medical
Founded:
2017-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.pearbio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
5.79 M USD
Technology used in webpage:
SPF Amazon Google Apps For Business GoDaddy DNS AWS Global Accelerator
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
VectivBio
VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.
Watchmaker Genomics
Watchmaker Genomics is a biotechnology company that focuses on breakthrough applications for reading, writing, and editing DNA.
Current Employees Featured
Founder
Investors List
Greater London Authority
Greater London Authority investment in Grant - Pear Bio
SOSV
SOSV investment in Seed Round - Pear Bio
Fly Ventures
Fly Ventures investment in Seed Round - Pear Bio
SOSV
SOSV investment in Convertible Note - Pear Bio
RebelBio
RebelBio investment in Convertible Note - Pear Bio
Official Site Inspections
http://www.pearbio.com Semrush global rank: 7 M Semrush visits lastest month: 647
Unable to get host informations!!!
More informations about "Pear Bio"
Pear Bio
We take tumor biopsies from patients, turn them into 3D immune-microtumors and test various treatment options side-by-side to predict response and match patients with an effective therapy. …See details»
Pearl Bio | Build next-gen Biomaterials for Smart Biologics
Pearl Bio’s manufacturing platform unites the precision of biology with the vast diversity of chemistry to create template-directed biomaterials with tunable …See details»
Pear Bio - Crunchbase Company Profile & Funding
Pear Bio is a Boston and London-based AI-enabled biotech company. We …See details»
Pear Bio - LinkedIn
Pear Bio | 8,011 followers on LinkedIn. Patient-centered cancer precision medicine | Pear Bio analyzes patient tumor samples and data with a proprietary computational biology platform to …See details»
Pipeline – Pear Bio
The goal of the study is to establish the accuracy of Pear’s test at predicting disease response to help guide future patients to better treatments. If you are interested in …See details»
Our Approach – Pear Bio
A pan-cancer computer vision pipeline analyzes complex cell behaviors over time using a combination of deep learning and traditional computer vision. Many dynamic behaviors ranging …See details»
Pear Bio - LinkedIn
Pear Bio analyzes patient tumor samples and data with a proprietary computational biology platform to deconvolute complex cancer biology and drive patient-centric functional precision medicine and ...See details»
Contact – Pear Bio
ABI-LAB 2, 22 Strathmore Rd, Natick, MA 01760, United StatesSee details»
The Pear Bio Platform – Pear Bio
Sep 5, 2024 Pear Bio have developed a novel Functional Precision Medicine platform that integrates biology and Artificial Intelligence to allow for rapid assessment of treatment efficacy in …See details»
News – Pear Bio
Check out our posters at the American Association for Cancer Research 2025: Abstract #3011 – Monday April 28th, 2-5PM Experimental & Molecular Therapeutics, Poster section 20, Board 12 – …See details»
Pear Bio - Profile
Pear Bio is a computational biology company that uses organ-on-a-chip and computer vision technology to recreate, visualize and compute the human tumor …See details»
Pear Bio | F6S
Pear Bio - Pear uses biomaterials + organ-on-a-chip technology to model the spread of cancer for precision medicine. Biomaterials model the local spread of cancer, and a microfluidic circulation …See details»
Pear Bio - 2025 Company Profile & Team - Tracxn
Jul 30, 2025 Pear Bio is a series A company based in London (United Kingdom), founded in 2017 by Duleek Ranatunga. It operates as a Developer of microfluidic chip for cancer drug research. …See details»
Pear Bio - Leadership Team | The Org
The Leadership Team at Pear Bio oversees the strategic direction and operational management of the company. They guide research and development in cancer treatment technologies, ensuring …See details»
Pear Bio - SOSV
Feb 6, 2025 Pear Bio is a computational biology company that has developed a functional precision medicine platform to optimize clinical cancer care and drug development. The platform uses …See details»
Pear Bio 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Pear Bio. Use the PitchBook Platform to explore the full profile.See details»
Presentation - pearbio.com
6 Get in touch www.pearbio.com Duleek Ranatunga – CEO – [email protected] Acknowledgements: Special thanks to the Pear Bio R&D, software, clinical trials and business …See details»
Meet Pear Bio: Revolutionising the way cancer treatments are …
Pear Bio is revolutionising the way cancer treatments are assigned to patients. They have developed a functional precision medicine platform by integrating tissue engineering, confocal microscopy, …See details»
Pear Bio Company Information - Funding, Investors, and More
Pear Bio, based in London, is disrupting healthcare with its cancer treatment predictor software. Operating on a B2B model, Pear Bio aims to enhance oncologists' decision-making through …See details»
Pear Bio | Velocity
Pear Bio has developed the Cancer Model Generator, a modular process to create 3D cell culture models for each type of cancer and use live-cell imaging and 3D computer vision to predict …See details»